Bank Of America Corp Ultragenyx Pharmaceutical Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Bank Of America Corp holds 925,910 shares of RARE stock, worth $43.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

925,910

Previous 547,818 69.02%

Holding current value

$43.7 Million

Previous $22.5 Million 128.44%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$40.21 - $59.36 $15.2 Million - $22.4 Million	378,092 Added 69.02%	925,910 $51.4 Million
Q2 2024 Aug 14, 2024	BUY	$37.42 - $51.61 $4.39 Million - $6.05 Million	117,282 Added 27.24%	547,818 $22.5 Million
Q1 2024 May 15, 2024	BUY	$43.02 - $53.69 $3.75 Million - $4.68 Million	87,124 Added 25.37%	430,536 $20.1 Million
Q4 2023 Feb 14, 2024	SELL	$31.73 - $49.19 $490,355 - $760,182	-15,454 Reduced 4.31%	343,412 $16.4 Million
Q2 2023 Aug 14, 2023	SELL	$37.35 - $52.15 $4.19 Million - $5.85 Million	-112,084 Reduced 23.8%	358,866 $16.6 Million
Q1 2023 May 12, 2023	BUY	$36.99 - $48.71 $2.91 Million - $3.83 Million	78,556 Added 20.02%	470,950 $18.9 Million
Q4 2022 Feb 10, 2023	BUY	$33.72 - $46.33 $849,676 - $1.17 Million	25,198 Added 6.86%	392,394 $18.2 Million
Q3 2022 Nov 14, 2022	SELL	$39.96 - $66.14 $1.86 Million - $3.08 Million	-46,535 Reduced 11.25%	367,196 $15.2 Million
Q2 2022 Aug 12, 2022	BUY	$45.8 - $85.4 $3.58 Million - $6.68 Million	78,248 Added 23.32%	413,731 $24.7 Million
Q1 2022 May 16, 2022	BUY	$62.2 - $84.4 $5.52 Million - $7.49 Million	88,687 Added 35.94%	335,483 $24.4 Million
Q4 2021 Feb 08, 2022	SELL	$73.71 - $87.86 $1.33 Million - $1.59 Million	-18,077 Reduced 6.82%	246,796 $20.8 Million
Q3 2021 Nov 15, 2021	BUY	$77.92 - $102.4 $2.21 Million - $2.9 Million	28,365 Added 11.99%	264,873 $23.9 Million
Q2 2021 Sep 13, 2021	BUY	$92.19 - $115.71 $21.8 Million - $27.4 Million	236,508 New	236,508 $22.6 Million

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.31B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Ultragenyx Pharmaceutical Inc. Transaction History